RU-SKI 43 hydrochloride is a potent and selective inhibitor of Hedgehog acyltransferase (Hhat) with an IC50 of 850 nM; it exhibits anticancer activity by reducing Gli-1 activation through a Smoothened-independent non-canonical signaling pathway and inhibiting Akt and mTOR pathway activities; it strongly suppresses cell proliferation in pancreatic cancer cells (AsPC-1 and Panc-1); it inhibits Shh palmitoylation in a dose-dependent manner; it decreases Gli-1 levels and reduces phosphorylation of key proteins in the Akt and mTOR signaling pathways, including Akt (Thr307 and Ser473), PRAS40, Bad, GSK-3β, mTOR, and S6.